Zhang D - Search Results

1

In vivo evaluation of silybin nanosuspensions targeting liver.

Wang Y, Wang L, Liu Z, Zhang D, Zhang Q. Wang Y, et al. Among authors: zhang q, zhang d. J Biomed Nanotechnol. 2012 Oct;8(5):760-9. doi: 10.1166/jbn.2012.1444. J Biomed Nanotechnol. 2012. PMID: 22888746

2

In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.

Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q. Wang Y, et al. Among authors: zhang q, zhang d, zhang x. Nanotechnology. 2010 Apr 16;21(15):155104. doi: 10.1088/0957-4484/21/15/155104. Epub 2010 Mar 23. Nanotechnology. 2010. PMID: 20332565

3

Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.

Jia L, Zhang D, Li Z, Duan C, Wang Y, Feng F, Wang F, Liu Y, Zhang Q. Jia L, et al. Among authors: zhang q, zhang d. Colloids Surf B Biointerfaces. 2010 Oct 15;80(2):213-8. doi: 10.1016/j.colsurfb.2010.06.008. Epub 2010 Jun 23. Colloids Surf B Biointerfaces. 2010. PMID: 20621458

4

A mini review of nanosuspensions development.

Liu Y, Xie P, Zhang D, Zhang Q. Liu Y, et al. Among authors: zhang q, zhang d. J Drug Target. 2012 Apr;20(3):209-23. doi: 10.3109/1061186X.2011.645161. Epub 2011 Dec 23. J Drug Target. 2012. PMID: 22192053 Review.

5

Development and in vitro characterizations of bifendate nanosuspensions.

Liu Y, Zhang D, Zou D, Wang Y, Duan C, Jia L, Xie P, Feng F, Wang F, Zhang X, Zhang Q. Liu Y, et al. Among authors: zhang q, zhang d, zhang x. J Biomed Nanotechnol. 2011 Oct;7(5):621-31. doi: 10.1166/jbn.2011.1330. J Biomed Nanotechnol. 2011. PMID: 22195479

6

Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery.

Wang Y, Ma Y, Ma Y, Du Y, Liu Z, Zhang D, Zhang Q. Wang Y, et al. Among authors: zhang q, zhang d. J Nanosci Nanotechnol. 2012 Aug;12(8):6176-84. doi: 10.1166/jnn.2012.6436. J Nanosci Nanotechnol. 2012. PMID: 22962724

7

Recent advances in the nanotechnology-based drug delivery of Silybin.

Wang Y, Zhang L, Wang Q, Zhang D. Wang Y, et al. Among authors: zhang l, zhang d. J Biomed Nanotechnol. 2014 Apr;10(4):543-58. doi: 10.1166/jbn.2014.1798. J Biomed Nanotechnol. 2014. PMID: 24734507 Review.

8

Preparation and characterization of silybin-loaded nanostructured lipid carriers.

Jia LJ, Zhang DR, Li ZY, Feng FF, Wang YC, Dai WT, Duan CX, Zhang Q. Jia LJ, et al. Drug Deliv. 2010 Jan;17(1):11-8. doi: 10.3109/10717540903431586. Epub 2009 Nov 26. Drug Deliv. 2010. PMID: 19941406

9

Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension.

Wang Y, Liu Z, Zhang D, Gao X, Zhang X, Duan C, Jia L, Feng F, Huang Y, Shen Y, Zhang Q. Wang Y, et al. Among authors: zhang q, zhang d, zhang x. Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):189-97. doi: 10.1016/j.colsurfb.2010.10.029. Epub 2010 Oct 21. Colloids Surf B Biointerfaces. 2011. PMID: 21176876

10

In vitro antitumor activity of silybin nanosuspension in PC-3 cells.

Zheng D, Wang Y, Zhang D, Liu Z, Duan C, Jia L, Wang F, Liu Y, Liu G, Hao L, Zhang Q. Zheng D, et al. Among authors: zhang q, zhang d. Cancer Lett. 2011 Aug 28;307(2):158-64. doi: 10.1016/j.canlet.2011.03.028. Epub 2011 Apr 19. Cancer Lett. 2011. PMID: 21507570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42,178 results

Search Page